Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Arkowitz David, Chief Financial Officer. Director active across 5 companies, notably Flexion Therapeutics Inc. Cumulatively, 11 disclosures have been logged. Split: 1 buy · 2 sells. Total volume traded: €67k. Activity tracked since 10 May 2021. The latest transaction was filed on 23 June 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Arkowitz David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,229 shares@ US$7.23100.0% of flowCommon StockSEC:0001209191-21-032103:0
11 of 11 declarations
About Arkowitz David
David Arkowitz is the Chief Financial Officer of Flexion Therapeutics Inc. He oversees the financial management of the company, including planning and financial reporting.